Shellya Puti Sudesty
Departement of Medical Biology, Molecular Biology, and Physiology, Faculty of Medicine, University of Lampung, Bandar Lampung, 35145, Indonesia

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Hypoxia: Adaptation Mechanisms and Their Impact on Organs Rifda El Mahroos; Shellya Puti Sudesty; Rifka Wangiana Yulia Putri
Journal of Diverse Medical Research : Medicosphere Vol. 3 No. 3 (2026): Journal of Diverse Medical Research : Medicosphere 2026
Publisher : Faculty of Medicine - Universitas Pembangunan Nasional Veteran Jawa Timur

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33005/jdiversemedres.v3i3.249

Abstract

Background: Hypoxia is a decrease in tissue oxygen that induces the activation of hypoxia-inducible factor (HIF) and cellular responses such as metabolic changes, angiogenesis, and inflammatory modulation. This initial adaptive response can become maladaptive with prolonged or repeated exposure. Methods: This article is a narrative review that examines literature from 2015–2025 from PubMed, ScienceDirect, and Google Scholar. Searches were conducted using keywords related to "hypoxia," "hypoxia-inducible factor (HIF)," "cellular adaptation," and "organ impacts," with selection based on relevance and scientific quality. Discussion: Hypoxia has various exposure patterns (acute, chronic, and intermittent) that trigger a body response through the activation of oxygen sensors and gene regulation by HIF. In the initial stages, the body attempts to maintain stable cell function. However, prolonged or repeated exposure renders this adaptive response ineffective and leads to tissue disruption. These impacts are seen in various organs, such as changes in heart structure, pulmonary vascular alterations, an increased tendency for fibrosis in the liver and kidneys, and a decreased integrity of the gastrointestinal epithelial barrier, all of which can contribute to disease. Conclusion: Hypoxia is a complex biological stimulus with dualistic effects that depend on the duration and intensity of exposure. This understanding is crucial for improving diagnostic and therapeutic strategies related to hypoxia. Keywords: hypoxia, HIF pathway, oxidative stress, organ dysfunction, inflammation
The Relationship Between Sleep Apnea and Chronic Kidney Disease: A Scoping Review: A Narrative Review rifda el mahroos; Rifka Wangiana Yulia Putri; Shellya Puti Sudesty; Zulfan Febriawan; Aktaruddin Arief Santoso
Journal of Diverse Medical Research : Medicosphere Vol. 3 No. 8 (2026): Journal of Diverse Medical Research : Medicosphere 2026
Publisher : Faculty of Medicine - Universitas Pembangunan Nasional Veteran Jawa Timur

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33005/jdiversemedres.v3i8.363

Abstract

Sleep apnea and chronic kidney disease (CKD) have a complex bidirectional effect. Sleep apnea accelerates the decline of kidney function through various mechanisms. CKD can worsen the severity of sleep apnea. This study aims to conduct a scoping review of studies discussing the relationship between sleep apnea and CKD. A scoping review was conducted through a systematic literature search in PubMed, Google Scholar, and ScienceDirect using keywords related to sleep apnea, CKD, and CPAP therapy. A total of 18 peer-reviewed articles meeting the inclusion criteria were analyzed. The prevalence of sleep apnea among CKD patients was found to be high, with a bidirectional relationship worsening both conditions. Sleep apnea was identified as an independent risk factor accelerating the progression of CKD. CPAP therapy demonstrated significant benefits in improving kidney function and reducing biomarkers of kidney injury, especially among patients with good treatment adherence. Variability in diagnostic methods and population characteristics influenced the study results. The relationship between sleep apnea and CKD is multifactorial and requires a multidisciplinary management approach. CPAP therapy has the potential to slow the progression of CKD.